Skip to content

Investigation of Metabolic Processes during Caloric Restriction and Subsequent Surplus

Investigation of Metabolic Processes during Caloric Restriction and Subsequent Surplus - EnergyRefeed

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036246
Enrollment
41
Registered
2025-03-05
Start date
2025-02-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.0

Interventions

Group 1: Caloric Deficit Followed by a Caloric Surplus: Study participants go through 3 days in energy balance, 3 days in an energy deficit (50% of their energy requirement), followed by 3 days in an

Sponsors

Technische Universität München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: -Age between 18 and 35 years -Body Mass Index (BMI) between 18.5 and 25 kg/m² -No history of disturbed eating behavior or eating disorders -No diagnosed metabolic diseases (e.g., no hypothyroidism, no diabetes mellitus) -No repeated major weight losses in the past -Weight fluctuations of =2.5 kg in the last 3 months -No vegan diet -No nutrient intolerance or food allergies -Women: Regular periods in the last three months (cycle length >35 days), no use of a hormonal IUD, not pregnant, and not breastfeeding

Exclusion criteria

Exclusion criteria: -Age 35 years -Body mass index 25 kg/m² -History of disturbed eating behavior/eating disorders -Diagnosed metabolic disease (e.g. hypothyroidism, diabetes mellitus) -Repeated major weight loss in the past -Weight fluctuations of >2.5 kg in the last 3 months -Vegan diet -Nutrient intolerance or food allergy -Women: no regular period in the last three months (cycle length >35 days), use of a hormonal IUD, pregnancy, or breastfeeding

Design outcomes

Primary

MeasureTime frame
The data is collected on the morning of the 4th day after each study phase (energy balance, energy deficit, energy surplus): -Respiratory Quotient, O2 consumption/CO2 production (metabolism of carbohydrates and fats), and blood glucose during an oral glucose tolerance test -Markers of energy metabolism (T3, insulin, glucagon, leptin, glucose, lactate, free fatty acids, glycerol) -Gene expression of marker enzymes of lipogenesis in adipocytes (Sterol Regulatory Element-Binding Protein-1c (SREBP-1c), Fatty Acid Synthase (FASN), Acetyl-Coenzyme A Carboxylase (ACC), and ATP Citrate Lyase (ACLY))

Secondary

MeasureTime frame
The data is collected on the morning of the 4th day after each study phase (energy balance, energy deficit, energy surplus): - Immun cell phenotyping - Changes in body weight and body composition (fat and fat-free mass)

Countries

Germany

Contacts

Public ContactPaulina Wasserfurth

Technische Universität München

paulina.wasserfurth@tum.de+49 (89) 289 - 24492

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026